Síndrome de TAR y estado de heterocigosis para anemia falciforme
Presentación de un paciente con el cuadro clínico del síndrome de TAR, quien presenta además un estado de heterocigosis para anemia falciforme. El síndrome de TAR, descrito por primera vez en 1959 por Shaw y Oliver, es un trastorno genético no común ...
Pilar Garavito +2 more
doaj
[Severe COVID: A challenge for rheumatologists]. [PDF]
Bernal-Enriquez MB.
europepmc +1 more source
[Association of platelets with multiple organic failure in septic patients]. [PDF]
Bocanegra-Alegría E +2 more
europepmc +1 more source
Use of single-pass albumin dialysis in a patient with acute liver failure due to dengue: A case report [PDF]
Carvajal C, Arias J, Torres S.
europepmc +1 more source
Position Statement on the Management of Antithrombotic and Anticoagulant Therapy in Dengue - 2026. [PDF]
Pitta FG +24 more
europepmc +1 more source
[Integrated care for long-responder women with metastatic breast cancer: Expert opinion for long term management in spain]. [PDF]
González V +5 more
europepmc +1 more source
[Rapidly involuting congenital hemangioma, diagnosed prenatally with heart failure and posnatal follow up] [PDF]
Santarelli A +3 more
europepmc +1 more source
Trombocitopenia inducida por fármacos
Introducción: Se define trombocitopenia como una reducción del número de plaquetas circulantes en sangre por debajo de 100,000-150,000/mm3. Según el recuento plaquetario, se clasifica en leve (>50,000/mm3), moderada (10,000-50,000/mm3) o grave (
Leal, Ángel, Inthamoussu, Maite
openaire +1 more source
[Side effects and pharmacovigilance of GLP1 agonists]. [PDF]
Maria Tablado MA.
europepmc +1 more source
[Multisystem inflammatory syndrome in a young infant with lymphocytosis and reactive thrombocytosis post COVID-19: Case report]. [PDF]
Vera-Rodríguez HA +5 more
europepmc +1 more source

